PlainRecalls
FDA Drug Moderate Class II Terminated

BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1

Reported: November 27, 2024 Initiated: November 6, 2024 #D-0051-2025

Product Description

BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1

Reason for Recall

Lack of Sterility Assurance

Details

Recalling Firm
Tailstorm Health INC
Units Affected
27,560 Syringes
Distribution
Nationwide Within U.S.
Location
Phoenix, AZ

Frequently Asked Questions

What product was recalled?
BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1. Recalled by Tailstorm Health INC. Units affected: 27,560 Syringes.
Why was this product recalled?
Lack of Sterility Assurance
Which agency issued this recall?
This recall was issued by the FDA Drug on November 27, 2024. Severity: Moderate. Recall number: D-0051-2025.